azathioprine has been researched along with Hyperglycemia, Postprandial in 15 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 9.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 5.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| " Is the evidence now sufficient to support the routine use of regimens including CNIs in LN? Although CNIs appear to have similar efficacy to MMF-based regimens as induction therapy, and are comparable with azathioprine as maintenance treatment, CNI toxicities, such as new-onset hypertension, hyperglycaemia and nephrotoxicity, have been problematic." | 3.83 | Con: The use of calcineurin inhibitors in the treatment of lupus nephritis. ( Fernandez Nieto, M; Jayne, DR, 2016) |
| "Post-transplant diabetes mellitus is a significant risk factor for cardiovascular disease in solid organ transplantation." | 2.52 | Immunosuppression and Post-transplant Hyperglycemia. ( Montero, N; Pascual, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montero, N | 1 |
| Pascual, J | 1 |
| Fernandez Nieto, M | 1 |
| Jayne, DR | 1 |
| Gonwa, T | 1 |
| Johnson, C | 1 |
| Ahsan, N | 1 |
| Alfrey, EJ | 1 |
| Halloran, P | 1 |
| Stegall, M | 1 |
| Hardy, M | 1 |
| Metzger, R | 1 |
| Shield, C | 1 |
| Rocher, L | 1 |
| Scandling, J | 1 |
| Sorensen, J | 1 |
| Mulloy, L | 1 |
| Light, J | 1 |
| Corwin, C | 1 |
| Danovitch, G | 1 |
| Wachs, M | 1 |
| VanVeldhuisen, P | 1 |
| Leonhardt, M | 1 |
| Fitzsimmons, WE | 1 |
| RIFKIND, D | 1 |
| MARCHIORO, TL | 1 |
| WADDELL, WR | 1 |
| STARZL, TE | 1 |
| Paterson, AJ | 1 |
| Lamey, PJ | 1 |
| Lewis, MA | 1 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Walker, RE | 1 |
| McCrindle, BW | 1 |
| Coles, JG | 1 |
| West, LJ | 1 |
| Roth, D | 1 |
| Milgrom, M | 1 |
| Esquenazi, V | 1 |
| Fuller, L | 1 |
| Burke, G | 1 |
| Miller, J | 1 |
| Amiel, JA | 1 |
| Toledo-Pereyra, LH | 1 |
| Hill, CM | 1 |
| Douglas, JF | 1 |
| Rajkumar, KV | 1 |
| McEvoy, J | 1 |
| McGeown, MG | 1 |
| Zimmermann, G | 1 |
| Hell, E | 1 |
| Anderson, RJ | 1 |
| Schafer, LA | 1 |
| Olin, DB | 1 |
| Eickhoff, TC | 1 |
| Gliedman, ML | 1 |
| Gold, M | 1 |
| Whittaker, J | 1 |
| Rifkin, H | 1 |
| Soberman, R | 1 |
| Freed, S | 1 |
| Tellis, V | 1 |
| Veith, FJ | 1 |
| Inou, T | 2 |
| Ota, K | 2 |
| Mori, S | 2 |
| Reemtsma, K | 1 |
| Giraldo, N | 1 |
| Depp, DA | 1 |
| Eichwald, EJ | 1 |
| Kanazawa, Y | 1 |
| Kuzuya, T | 1 |
1 review available for azathioprine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Ever | 2015 |
1 trial available for azathioprine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; | 2003 |
13 other studies available for azathioprine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Hyperglycemia; Hyperte | 2016 |
INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION.
Topics: Adolescent; Agammaglobulinemia; Agranulocytosis; Azathioprine; Bacteriophage Typing; Child; Diagnosi | 1964 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; | 1998 |
Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
Topics: Actuarial Analysis; Adult; Azathioprine; Cyclosporins; Diabetes Mellitus; Female; Graft Survival; Hu | 1989 |
[Transplantation of pancreatic islets in dogs--a new method].
Topics: Animals; Azathioprine; Dogs; Hyperglycemia; Immunosuppression Therapy; Islets of Langerhans Transpla | 1986 |
Glycosuria and hyperglycaemia after kidney transplantation.
Topics: Acute Disease; Azathioprine; Glucose Tolerance Test; Glycosuria; Humans; Hydrocortisone; Hyperglycem | 1974 |
[Transplantation and preservation by freezing of the pancreas in dogs].
Topics: Amylases; Animals; Azathioprine; Dogs; Female; Freezing; Glucose Tolerance Test; Graft Rejection; Gr | 1971 |
Infectious risk factors in the immunosuppressed host.
Topics: Adolescent; Adult; Agammaglobulinemia; Age Factors; Antilymphocyte Serum; Azathioprine; Child; Femal | 1973 |
Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage.
Topics: Adult; Azathioprine; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; Hyperglycemi | 1973 |
Manifestations of rejection of pancreaticoduodenal allografts.
Topics: Amylases; Animals; Azathioprine; Blood Glucose; Dogs; Duodenum; Histocompatibility; Hyperglycemia; I | 1968 |
Islet cell transplantation.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Female; Hyperglycemia; Male; Mercaptopurine; Pancreas; P | 1968 |
Endocrine function of the pancreatic allograft.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Glucose Tolerance Test; Graft vs Host Disease; Hyperglyc | 1968 |